fda compounding glp-1 warning letters september 2025 Sends to More Than 50 Compounders and Manufacturers FDA issues 30 warning letters

The result is a thinner but deflated, saggy appearance that doesn't match what most people envisioned when they started the medication

Dominique Delsart

"But if there needs to be menu innovation around that, we will do that." RRD's Baggett told CNBC that she thinks portions and snack sizing will be key for restaurants to attract consumers who are on GLP-1 treatments

Users transitioning from lower-purity compounded MT2 to research-grade peptides often report stronger efficacy at equivalent doses due to higher actual peptide content per milligram.

But whether the thymus function is the thing that's causing those effects remains to be determined